Level Bio Investor Relations Material
Latest events
Q1 2025
Level Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Level Bio
Access all reports
Level Bio is a biotechnology company focused on the development of innovative solutions in the life sciences sector. The company engages in research and product development aimed at addressing challenges in healthcare, leveraging advanced technologies and scientific expertise. Level Bio serves industries such as pharmaceuticals, diagnostics, and medical research with applications designed to improve patient care and treatment outcomes. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
LEVBIO
Country
🇸🇪 Sweden